TSE:5201
TSE:5201Building

A Look at AGC (TSE:5201) Valuation Following New mRNA Therapy Collaboration with Repair Biotechnologies

AGC (TSE:5201) saw investor attention this week following news that its Biologics division is partnering with Repair Biotechnologies to co-develop a groundbreaking mRNA therapy for atherosclerotic plaques, which is a significant global health issue. See our latest analysis for AGC. AGC’s recent collaboration news arrived as momentum was already building. Its 12.8% 1-month share price return and 20.8% total shareholder return over the past year show investors aren’t just reacting to headlines,...